Risk Assessment and Treat Compliance in Hypertension Education Trial

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
HypertensionDyslipidemia
Interventions
BEHAVIORAL

Knowledge of Cardiovascular Risk Assessment

Knowledge of Cardiovascular Risk Assessment and risk reduction at target BP, reviewed every 3-6 months.

Trial Locations (1)

N6A 5A5

University of Western Ontario, London

All Listed Sponsors
collaborator

University of Western Ontario, Canada

OTHER

collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT00694239 - Risk Assessment and Treat Compliance in Hypertension Education Trial | Biotech Hunter | Biotech Hunter